Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00516906 | Clinical Performance of a Chlorhexidine Antimicrobial Dressing | PHASE2 | COMPLETED | 68 | — | — | Oct 1, 2007 | Jan 1, 2008 | Oct 24, 2024 | - | — |
Clinician Overall Satisfaction with Catheter Securement Five Point Scale: 1 = Very Good, 5= Very Poor
| Arm | Type | Description |
|---|---|---|
| Transparent Adhesive Dressing | PLACEBO_COMPARATOR | Standard of Care Non-Antimicrobial Transparent Adhesive Dressing |
| CHG antimicrobial transparent dressing | EXPERIMENTAL | Chlorhexidine gluconate antimicrobial transparent adhesive dressing |
| Name | Type | Description |
|---|---|---|
| Chlorhexidine gluconate | DRUG | 2% Chlorhexidine Transparent Dressing applied as needed up to 7 days of wear |
| Transparent Adhesive Dressing | DRUG | Standard of Care Non-antimicrobial Transparent Adhesive Dressing applied as needed for up to 7 days of wear |
Inclusion Criteria: * Males or Females over 18 years of age * Patients with an existing, or newly inserted, central venous catheter * Patients who require the catheter for at least 3 days Exclusion Criteria: * Sensitivity to chlorhexidine